UK markets closed

Johnson Chemical Pharmaceutical Works Co., Ltd. (4747.TWO)

Taipei Exchange - Taipei Exchange Delayed price. Currency in TWD
Add to watchlist
74.20+1.20 (+1.64%)
At close: 01:30PM CST
Currency in TWD

Valuation measures4

Market cap (intra-day) 3.24B
Enterprise value 2.31B
Trailing P/E 34.04
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)4.64
Price/book (mrq)1.94
Enterprise value/revenue 3.81
Enterprise value/EBITDA 18.27

Trading information

Stock price history

Beta (5Y monthly) -0.33
52-week change 341.86%
S&P500 52-week change 322.36%
52-week high 3122.50
52-week low 349.40
50-day moving average 375.59
200-day moving average 388.89

Share statistics

Avg vol (3-month) 3305.14k
Avg vol (10-day) 3268.2k
Shares outstanding 543.67M
Implied shares outstanding 643.67M
Float 8N/A
% held by insiders 130.84%
% held by institutions 10.00%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 42
Forward annual dividend yield 42.70%
Trailing annual dividend rate 31.50
Trailing annual dividend yield 32.05%
5-year average dividend yield 44.09
Payout ratio 491.74%
Dividend date 3N/A
Ex-dividend date 412 Jun 2023
Last split factor 21125:1000
Last split date 330 Jul 2014

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 13.14%
Operating margin (ttm)12.77%

Management effectiveness

Return on assets (ttm)4.07%
Return on equity (ttm)6.27%

Income statement

Revenue (ttm)606.71M
Revenue per share (ttm)17.04
Quarterly revenue growth (yoy)9.60%
Gross profit (ttm)N/A
EBITDA 119.94M
Net income avi to common (ttm)79.7M
Diluted EPS (ttm)2.18
Quarterly earnings growth (yoy)-5.00%

Balance sheet

Total cash (mrq)1.09B
Total cash per share (mrq)24.91
Total debt (mrq)160.83M
Total debt/equity (mrq)9.62%
Current ratio (mrq)6.18
Book value per share (mrq)38.29

Cash flow statement

Operating cash flow (ttm)136.95M
Levered free cash flow (ttm)80.62M